newsfilter
← Latest News
ACCESS Newswire·

Biophytis Announces 2022 Financial Results and 2023 Perspectives

€11.1M of available cash and equivalents on December 31, 2022, and financing instruments for a total of €22M allowing financial visibility beyond mid 2024Positive results of the Phase 2-3 COVA study for the